CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Maternal exposures in the National Birth Defects Prevention Study: time trends of selected exposures
-
8 2015
-
-
Source: Birth Defects Res A Clin Mol Teratol. 103(8):703-712
Details:
-
Alternative Title:Birth Defects Res A Clin Mol Teratol
-
Personal Author:
-
Description:Background
Our objective was to describe time trends in selected pregnancy exposures in the National Birth Defects Prevention Study (NBDPS).
Methods
We analyzed data from the NBDPS, a multi-site case-control study of major birth defects, for mothers of live-born infants without birth defects (controls), with an expected date of delivery (EDD) from 1998 –2011. Mothers from the 10 participating centers across the United States were interviewed by phone between six weeks and two years after the EDD. We focused on maternal race/ethnicity and five maternal risk factors: obesity, use of folic acid-containing multivitamins, opioid analgesics, selective serotonin reuptake inhibitors (SSRIs), and loratadine because of their prevalence of use and some reports of associations with major birth defects. Prevalence time trends were examined using the Kendall’s τβ test statistic.
Results
The exposure trend analysis included 11,724 control mothers with EDDs from 1998–2011. We observed a significant increase in obesity prevalence among control mothers, as well as use of SSRIs and loratadine. We also observed an increase in periconceptional use of folic acid-containing multivitamins. Some of the time trends varied by race/ethnicity. No remarkable trend in the overall use of opioid analgesics was observed. The racial/ethnic distribution of mothers changed slightly during the study period.
Conclusions
Long-term, population-based case-control studies continue to be an effective way to assess exposure-birth defects associations and provide guidance to health care providers. However, investigators examining rare outcomes covering many years of data collection need to be cognizant of time trends in exposures.
-
Keywords:
-
Source:
-
Pubmed ID:25884728
-
Pubmed Central ID:PMC4617636
-
Document Type:
-
Funding:
-
Volume:103
-
Issue:8
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: